1,819
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Design and synthesis of novel oridonin analogues as potent anticancer agents

, , , , , & show all
Pages 324-333 | Received 22 Oct 2017, Accepted 13 Dec 2017, Published online: 05 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chen-Liang Zhao, Chi-Yuan Zhang, Xiao-Min Yang, Ka Hei Lam, Yi-Xuan Xia, Yin-Xiao Du, Lu-Tai Pan & Hong-Jie Zhang. Design and synthesis of oridonin derivatives as cytotoxic agents. Natural Product Research 0:0, pages 1-9.
Read now

Articles from other publishers (14)

Jialin Yao, Lu Liu, Qingxiang Sun & Xiaofei Shen. (2023) Direct cellular targets and anticancer mechanisms of the natural product oridonin. MedComm – Future Medicine 2:1.
Crossref
Pedro J. M. Sobral, André T. S. Vicente & Jorge A. R. Salvador. (2023) Recent advances in oridonin derivatives with anticancer activity. Frontiers in Chemistry 11.
Crossref
Hao Deng, Qian Xu, Hong-Yan Guo, Xing Huang, Fener Chen, Lili Jin, Zhe-Shan Quan & Qing-Kun Shen. (2023) Application of cinnamic acid in the structural modification of natural products: A review. Phytochemistry 206, pages 113532.
Crossref
T. Arokia Femina, V. Barghavi, K. Archana, N.G. Swethaa & Ravi Maddaly. (2023) Non-uniformity in in vitro drug-induced cytotoxicity as evidenced by differences in IC50 values – implications and way forward. Journal of Pharmacological and Toxicological Methods 119, pages 107238.
Crossref
Junkai Liu, Shaowen Xie, Xiao Shao, Songtao Xue, Pian Du, Hongyu Wu, Shengtao Xu, Zhe-Sheng Chen, Dong-Hua Yang, Jinyi Xu & Hong Yao. (2022) Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin. European Journal of Medicinal Chemistry 231, pages 114155.
Crossref
Myong Hak Ri, Juan Ma & Xuejun Jin. (2021) Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. Journal of Ethnopharmacology 281, pages 114370.
Crossref
Yong-Feng Guan, Xiu-Juan Liu, Xiao-Jing Pang, Wen-Bo Liu, Guang -Xi Yu, Yin -Ru Li, Yan-Bing Zhang, Jian Song & Sai-Yang Zhang. (2021) Recent progress of oridonin and its derivatives for cancer therapy and drug resistance. Medicinal Chemistry Research 30:10, pages 1795-1821.
Crossref
Xi Liu, Jimin Xu, Jia Zhou & Qiang Shen. (2021) Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance. Genes & Diseases 8:4, pages 448-462.
Crossref
Xu Hu, Yan Wang, Xiang Gao, Shengtao Xu, Linghe Zang, Yan Xiao, Zhanlin Li, Huiming Hua, Jinyi Xu & Dahong Li. (2020) Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia. Mini-Reviews in Medicinal Chemistry 20:6, pages 483-497.
Crossref
Yani Lin, Miaomiao Yu & Tingjun Fan. (2020) Insights into mechanisms of pranoprofen-induced apoptosis and necroptosis in human corneal stromal cells. Toxicology Letters 320, pages 9-18.
Crossref
Emma K Davison & Margaret A Brimble. (2019) Natural product derived privileged scaffolds in drug discovery. Current Opinion in Chemical Biology 52, pages 1-8.
Crossref
Huahong Yang, Yun Gao, Xiaoye Fan, Xingkai Liu, Liping Peng & Xinxin Ci. (2019) Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells. Frontiers in Oncology 9.
Crossref
Qing-Kun Shen, Hao Deng, Shi-Ben Wang, Yu-Shun Tian & Zhe-Shan Quan. (2019) Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway. European Journal of Medicinal Chemistry 173, pages 15-31.
Crossref
Yuan Qu, Hui-Ying Liu, Xiao-Xi Guo, Yan Luo, Cheng-Xiao Wang, Jiang-Hua He, Tian-Rui Xu, Ye Yang & Xiu-Ming Cui. (2018) Converting ginsenosides from stems and leaves of Panax notoginseng by microwave processing and improving their anticoagulant and anticancer activities . RSC Advances 8:70, pages 40471-40482.
Crossref